NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 343 filers reported holding NATERA INC in Q2 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $583,659 | -12.2% | 13,190 | -3.4% | 0.00% | 0.0% |
| Q2 2023 | $664,452 | -6.5% | 13,655 | +6.7% | 0.00% | 0.0% |
| Q1 2023 | $710,378 | +33.2% | 12,795 | -3.6% | 0.00% | 0.0% |
| Q4 2022 | $533,297 | -25.9% | 13,276 | -19.1% | 0.00% | 0.0% |
| Q3 2022 | $720,000 | +18.0% | 16,410 | -4.6% | 0.00% | 0.0% |
| Q2 2022 | $610,000 | -7.3% | 17,205 | +6.3% | 0.00% | 0.0% |
| Q1 2022 | $658,000 | -47.8% | 16,180 | +20.0% | 0.00% | -50.0% |
| Q4 2021 | $1,260,000 | -6.7% | 13,482 | +11.2% | 0.00% | -33.3% |
| Q3 2021 | $1,351,000 | +2.0% | 12,123 | +3.9% | 0.00% | +50.0% |
| Q2 2021 | $1,325,000 | -53.9% | 11,670 | -58.8% | 0.00% | -66.7% |
| Q1 2021 | $2,873,000 | +34.5% | 28,297 | +31.9% | 0.01% | +20.0% |
| Q4 2020 | $2,136,000 | +115.5% | 21,458 | +56.4% | 0.01% | +150.0% |
| Q3 2020 | $991,000 | +639.6% | 13,724 | +410.0% | 0.00% | – |
| Q2 2020 | $134,000 | +123.3% | 2,691 | +35.2% | 0.00% | – |
| Q1 2020 | $60,000 | +17.6% | 1,991 | +31.8% | 0.00% | – |
| Q4 2019 | $51,000 | +82.1% | 1,511 | +80.1% | 0.00% | – |
| Q3 2019 | $28,000 | -67.4% | 839 | -72.9% | 0.00% | – |
| Q2 2019 | $86,000 | +855.6% | 3,099 | +575.2% | 0.00% | – |
| Q1 2019 | $9,000 | +800.0% | 459 | +341.3% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 104 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 104 | 0.0% | 0.00% | – |
| Q2 2018 | $2,000 | +100.0% | 104 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 104 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 104 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 104 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | – | 104 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |